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The  increasing  reports  of  Aelurostrongylus  abstrusus  infection  and  the new  information  on
Troglostrongylus  brevior  have  spurred  the  interest  of the  scientiﬁc  community  towards  the
research  of  pharmaceutical  compounds  effective  against  both  pathogens.  A  novel  topi-
cal  combination  of ﬁpronil,  (S)-methoprene,  eprinomectin  and  praziquantel  (Broadline®,
Merial) has  been  released  for the treatment  of a  variety  of feline  parasitic  infections.  The
present  study  reports  the  efﬁcacy  of  this  spot-on  in treating  cats  naturally  infected  by  feline
lungworms.  Client  owned  cats (n  = 191)  were  enrolled  from  three  geographical  areas  of Italy
and faecal  samples  were  examined  by ﬂoatation  and Baermann  techniques.  Twenty-three
individuals  were  positive  for L1 of A. abstrusus  (n = 18) or T. brevior  (n =  3) or for both  species
(n  =  2)  and  they  were  topically  treated  with  Broadline®.  Seventeen  of  them  were  also  con-
comitantly  infected  by  other  parasites.  Four  weeks  after  treatment,  faecal  samples  were
collected  and  examined  to  assess  the  efﬁcacy  of  a single  administration  of the  product.
Based  on lungworm  larvae  counts,  the  efﬁcacy  of  the  treatment  was 90.5%  or  100%  for
A. abstrusus  or  T.  brevior,  respectively.  Cats  released  signiﬁcantly  lower  amounts  of lung-
worm larvae  after  treatment  compared  to pre-treatment  (p  < 0.0001).  All  but  three  cats
were negative  for  other  nematodes  after  treatment  and  all cats recovered  from  respiratory
signs. Results  of  this  study  indicate  that  a  single  administration  of  the topical  combina-
tion  ﬁpronil,  (S)-methoprene,  eprinomectin  and  praziquantel  is  effective  and safe for the
treatment  of A. abstrusus  and/or  T.  brevior  infections  in cats living  under  ﬁeld  conditions.
© 2015  The  Authors.  Published  by  Elsevier  B.V.  This  is an  open  access  article  under  the  CC
Y-NC-NB Broadline® is a trademark of Merial. All other marks are the property
f  their respective owners.
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1. Introduction
Domestic cats may  be infected by several endopara-
sites, which may  cause a variety of clinical signs, ranging
from digestive alterations to anaemia, and respiratory dis-
tress (Beugnet et al., 2014). Gastrointestinal helminths,
protozoans and lungworms are accounted as the major
ss article under the CC BY-NC-ND license (http://creativecommons.org/
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cause of parasitic diseases in cats across Europe (Beugnet
et al., 2014). Some of these species (e.g., Toxocara cati,
Toxoplasma gondii,  Giardia lamblia) represent a risk for
human beings (Traversa, 2012), whereas others (e.g., lung-
worms), though are not of zoonotic concern, may  be
highly pathogenic for cats and cause severe life-threatening
conditions (Gerdin et al., 2011). In addition, some intesti-
nal parasites may  cause self-limited infections but their
presence is not acceptable by owners. Consequently, the
administration of an efﬁcacious treatment against these
pathogens, as well as the prevention of the infection, repre-
sents either an act of responsibility towards animal welfare
and Public Health.
Among the lungworms infecting cats, Aelurostrongy-
lus abstrusus (Strongylida, Angiostrongylidae) is the most
prevalent species across Europe (Beugnet et al., 2014) and
several ﬁeld studies have provided data on the useful-
ness of anthelmintic treatments against this nematode
(Traversa et al., 2009; Iannino et al., 2013). Nonetheless, the
recent report of feline troglostrongylosis by Troglostrongy-
lus brevior (Strongylida, Crenosomatidae), along with the
little information available on its treatment and biol-
ogy, has spurred the interest of the scientiﬁc community
towards the research of pharmaceutical compounds effec-
tive against both pathogens (Brianti et al., 2012).
Recently, a novel topical combination of ﬁpronil 8.3%
(w/v), (S)-methoprene 10% (w/v), eprinomectin 0.4%
(w/v) and praziquantel 8.3% (w/v) (Broadline®, Merial),
hereinafter referred to as the product, has been registered
for the treatment of a broad spectrum of parasites-
causing infections in cats (e.g., Dipylidium caninum,
Taenia taeniaeformis,  Echinococcus multilocularis,  Ancy-
lostoma tubaeforme, Diroﬁlaria immitis, Ctenocephalides
felis, Ixodes ricinus) (Rehbein et al., 2014). The main
active ingredient, which is effective against nematodes
(i.e., eprinomectin), belongs to the avermectin family
and it affects pathogens by irreversibly opening the
glutamate-gated chloride ion channels and inducing cell
hyperpolarization (Wolstenholme, 2012). This product has
been tested in domestic cats for safety and efﬁcacy against
natural nematode and tapeworm infections, and was
demonstrated highly efﬁcacious against ascarids (i.e., T.
cati and Toxascaris leonina), hookworms (i.e., A. tubaeforme
and Ancylostoma braziliense)  and Capillaria (syn. Eucoleus)
spp. (Rehbein et al., 2014). Moreover, in a single study
conducted under experimental conditions, the product
showed to be highly effective for the treatment of different
developmental stages of A. abstrusus in cats (Knaus et al.,
2014a). However, this formulation has never been tested
in cats living under natural conditions, where multiple
infections may  occur, as well as in T. brevior-infected
animals. Therefore, the aim of the present study was  to
assess the efﬁcacy of Broadline® spot-on in cats naturally
infected by A. abstrusus and/or T. brevior.
2. Material and methods2.1. Prevalence of endoparasite infections in cats at the
enrolment
A ﬁeld trial study was conducted in three geograph-
ical sites of Italy, (i.e., Messina, Sassari and Bari), wheretology 209 (2015) 273–277
the occurrence of feline lungworm infections had been
previously reported (Brianti et al., 2012; Annoscia et al.,
2014; Giannelli et al., 2014a; Tamponi et al., 2014). From
May  to September 2014, client owned cats, which had reg-
ular access to the outdoor environment, were clinically
examined. Following the receipt of the owners’ informed
consent, anamnestic data (i.e., age, gender, clinical pre-
sentation and weight) were collected and faecal samples
were examined for gastrointestinal parasites and lung-
worm nematodes. In particular, faeces (at least 10 g) were
subjected to ﬂotation with ZnSO4 (speciﬁc gravity = 1.2)
and quantitative Baermann technique, as described else-
where (MAFF, 1986; Zajac and Conboy, 2012). Brieﬂy, faecal
samples were placed into Baermann funnels, ﬁlled with
50 ml  warm tap water and, after 24 h, the liquid was col-
lected into a tube and centrifuged at 2500 rpm (600 × g)
for 5 min. Finally, the supernatant was removed and the
sediment was  examined on a microscope slide. The whole
number of larvae was counted and lungworms were iden-
tiﬁed at species level (Gerichter, 1949; Giannelli et al.,
2014b), thus assessing the number of larvae per gram (Lpg)
and the presence of co-infections. Parasites in the faeces
were identiﬁed based on their morphology (Euzeby, 1981;
MAFF, 1986).
2.2. Evaluation of treatment against lungworms
Cats positive for lungworm larvae were enrolled in the
study if owners consented to treatment with Broadline®
spot-on and to subsequent follow-up. The product was
administered topically on the midline of the neck, between
the base of the skull and the shoulder blades, in a
single spot, as described in the label. Speciﬁcally, cats
weighing 0.8–2.5 kg received 0.3 ml  dose, while ani-
mals weighing 2.5–7.5 kg received a dose of 0.9 ml.  The
owners were requested to report any health problems or
adverse events during the course of the study and ani-
mals were followed-up 28 ± 2 days after treatment, with
clinical and faecal examinations performed as described
above.
2.3. Data analysis
A. abstrusus and T. brevior Lpg were transformed into
the natural logarithm (count +1) for calculation of geomet-
ric means for each species. The efﬁcacy of the treatment
was  calculated as percentage, using the formula: efﬁcacy
(%) = 100[(C − T)/C], where C was  the geometric mean of lar-
vae before the treatment and T was  the geometric mean
following the administration of the product. The change
in counts was  analysed by modelling the logarithm of
the counts +1 by a repeated measures analysis of vari-
ance, where the measurement time (pre-treatment versus
post-treatment) was  the repeated measurement within the
individual animal. The mixed procedure in SAS® Version
9.1.3 was  used for the analysis with measurement time
deﬁned, as the ﬁxed effect as well as repeated measure, and
animal deﬁned as the subject. All analyses were two-sided
at the signiﬁcance level of  ˛ = 0.05.
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Table  1
Number and prevalence of cats infected by gastrointestinal parasites and lungworm nematodes in each sampling area.
Pathogens Sampling areas
Messina (n = 23) Sassari (n = 111) Bari (n = 57) Total (n = 191)
Gastrointestinal parasites
Toxocara cati 5 (21.7%) 13 (11.7%) 11 (19.3%) 29 (15.2%)
Ancylostoma tubaeforme 14 (60.9%) 9 (8.1%) 0 23 (12%)
Cystoisospora felis 2 (8.7%) 21 (18%) 0 23 (12%)
Taenia  taeniformis 0 4 (3.6%) 0 4 (2.1%)
Dipylidium caninum 2 (8.7%) 0 7 (12.3%) 9 (4.7%)
Giardia lamblia 0 9 (8.1%) 0 9 (4.7%)
Strongyloides spp. 0 1 (0.9%) 0 1 (0.5%)
Lungworms
Aelurostrongylus abstrusus 11 (47.8%) 22 (19.8%) 1 (1.8%) 34 (17.8%)
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. Results
.1. Prevalence of endoparasite infections in cats at the
nrolment
Results of faecal examinations are reported in
ables 1 and 2. Out of 191 cats examined (i.e., 84
ale, 107 female), 87 (45.5%) were positive for either
astrointestinal parasites and/or lungworm nematodes. In
articular, 29 cats (15.2%) were infected by T. cati, 23 (12%)
y A. tubaeforme,  23 (12%) by Cystoisospora felis, 9 (4.7%)
y G. lamblia, 13 (6.8%) by tapeworms (i.e., 9 D. caninum
nd 4 T. taeniformis) and 1 (0.5%) by Strongyloides spp. In
ddition, 34 animals (17.8%) were infected by A. abstrusus, (3.1%) by T. brevior,  and one cat (0.5%) by Capillaria
erophila (syn. Eucoleus aerophilus).  Mixed-infections
y two or more pathogens were reported in 35 (18.3%)
nimals (Table 2) and one cat was co-infected by the
able 2
requency of diagnosis of single or mixed parasite infections in cats of different a
Parasite species <6 months (n = 77) 6 month
Single infections
Toxocara cati (T. c) 6 (7.8%) 2 (3.4%) 
Dipylidium caninum (D. c.) 0 1 (1.7%) 
Taenia taeniformis (T. t) 0 0 
Ancylostoma tubaeforme (HW) 1 (1.3%) 1 (1.7%) 
Cystoisospora felis (C. f.) 11 (14.3%) 0 
Giardia lamblia (G. l.) 5 (6.5%) 2 (3.4%) 
Lungworms (LW) 5 (6.5%) 7 (9.1%) 
Strongyloides spp. 0 0 
Mixed infections
T. c. + HW 0 1 (1.7%) 
T.  c. + TW 1 (1.3%) 1 (1.7%) 
T.  c. + LW 1 (1.3%) 1 (1.7%) 
T.  c. + C. f. 5 (6.5%) 0 
G.  l. + LW 1 (1.3%) 0 
HW  + LW 0 7 (9.1%) 
T.  t. + LW 0 0 
D.  c. + HW 0 0 
T.  c. + HW + C. f. 2 (2.6%) 0 
T.  c. + D. c. + LW 3 (3.9%) 0 
T.  c. + HW + LW 0 1 (1.7%) 
D.  c. + HW + LW 0 1 (1.7%) 
HW  + C. f. + LW 0 0 
T.  c. + HW + C. f. + G. l. 1 (1.3%) 0 
T.  c. + HW + C. f. + LW 1 (1.3%) 0 8%) 3 (5.3%) 6 (3.1%)
0 1(0.5%)
three lungworm species (i.e., A. abstrusus, T. brevior and E.
aerophilus), and two  cats were infected by A. abstrusus and
T. brevior.
3.2. Evaluation of treatment against lungworms
Twenty-three cats (13 male and 10 female), ranging
from 2 months to 7 years of age, were positive for A.
abstrusus (n = 18) or T. brevior (n = 3) or for both species
(n = 2) and were enrolled in the efﬁcacy study (Fig. 1). In
particular, 17 (73.9%) were co-infected with up to three
gastrointestinal parasites: 7 animals (30.4%) were positive
for A. tubaeforme; 2 (8.7%) for tapeworms (one D. caninum
and one T. taeniformis); 1 (4.3%) for T. cati, 1 for A. tubae-
forme and D. caninum; 2 for A. tubaeforme and T. cati, 1 for
T. taeniformis and T. cati, 1 for A. tubaeforme, T. cati and E.
aerophilus, 2 for A. tubaeforme,  T. cati and C. felis.
ge groups.
s–2 years (n = 59) >2 years (n = 55) Total (n = 191)
0 8 (4.2%)
2 (3.6%) 3 (1.6%)
1 (1.8%) 1 (0.5%)
1 (1.8%) 3 (1.6%)
1 (1.8%) 12 (6.3%)
0 7 (3.6%)
4 (7.3%) 16 (8.4%)
1 (1.8%) 1 (0.5%)
1 (0.5%)
2 (3.6%) 4 (2.1%)
2 (1.1%)
0 5 (2.6%)
0 1 (0.5%)
1 (1.8%) 8 (4.2%)
1 (1.8%) 1 (0.5%)
1 (1.8%) 1 (0.5%)
0 2 (1.1%)
0 3 (1.6%)
0 1 (0.5%)
1 (1.8%) 2 (1.1%)
1 (1.8%) 1 (0.5%)
0 1 (0.5%)
1 (1.8%) 2 (1.1%)
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Fig. 1. First-stage larvae (L1) of Troglostrongylus brevior (A) and Aelurostrongylus abstrusus (B) (Scale bar = 50 m).
Table 3
Lugworm larval counts before and 28 ± 2 days after treatment, percentage efﬁcacy and results of data analysis.
Lungworms Mean number of Lpga (range)
Pre-treatmentb Day 28 (±2) % Efﬁcacyc p-valued
NI/Ne GMf (range) NI/Ne GMf (range)
A. abstrusus 20/23 43.9 (1–1700 Lpg) 8/23 4.2 (0–1000 Lpg) 90.5 <0.0001
T.  brevior 5/23 23.9 (3–85 Lpg) 0/23 0 100 <0.0001
a Lpg = larvae per gram of faeces.
b Treatment = Broadline® .
c Percentage efﬁcacy = 100[(C − T)/C], where C and T are the geometric mean faecal larvae counts prior to treatment and at Day 28 (±2), respectively.
d Probability value analysed by modelling the logarithm of the counts +1 by a repeated measures analysis of variance where the measurement time
ithin th
 number(pre-treatment versus post-treatment) was  the repeated measurement w
e NI/N = Number of cats that had evidence of the indicated parasite per
f GM = geometric mean.
Faecal nematode larval counts before and after treat-
ment (day 28 ± 2), percentage efﬁcacy and results of data
analysis are reported in Table 3. At the enrolment, cats
shed a mean of 43.9 or 23.9 Lpg of A. abstrusus or T. brev-
ior, respectively. Seven cats (30.4%) infected by A. abstrusus
displayed severe respiratory signs (i.e., dyspnoea, recur-
rent cough, nasal discharge, wheezing), while one animal
co-infected by T. brevior and T. cati had diarrhoea.
Post-treatment larval counts of both metastrongyloid
species were signiﬁcantly reduced (p < 0.0001) and clini-
cal respiratory signs resolved in all treated animals. Fifteen
(65.2%) cats tested negative for lungworm larvae after a
single treatment. The overall efﬁcacy with Broadline® was
90.5% or 100% for A. abstrusus or T. brevior,  respectively. In
addition, 20 (87%) cats were negative for gastrointestinal
parasites whereas three (13%) shed eggs of A. tubaeforme,
E. aerophilus or T. cati, respectively. No health problems
related to the treatment were observed.
4. DiscussionsThe high prevalence of the infection for any helminthic
parasite (i.e., 45.5%) suggests that cats living in the
regions examined are exposed to the infection withe individual animal.
 of cats treated.
several pathogen species throughout their life, according to
their age, life style and the environment where they live.
Indeed, kittens tend to be more often infected by proto-
zoans (e.g., C. felis and G. lamblia) and ascarids (i.e., T. cati),
than adult cats. This trend has been conﬁrmed in stud-
ies on T. cati and C. felis, in which it has been shown that
infected cats ≤9 months of age are at higher risk for those
pathogens (Beugnet et al., 2014; Knaus et al., 2014b). Con-
versely, in the present study the age of animals was not
a risk factor for lungworm infection, since either young
or adult animals were infected by A. abstrusus or T. bre-
vior. However, the severity of troglostrongylosis may  be
correlated with the age of the individual, with fatal out-
comes observed in kittens (Brianti et al., 2014; Giannelli
et al., 2014a,b). Further studies should assess whether the
occurrence of mixed infections increase the pathogenicity
of feline metastrongyloids. However, there is an indication
that simultaneous infections with more than one species
of lungworms may  worsen the severity of clinical signs
(Varcasia et al., 2015).Results of this study indicate that a single adminis-
tration of the combination of ﬁpronil, (S)-methoprene,
eprinomectin and praziquantel is effective for the treat-
ment of A. abstrusus (90.5%) and T. brevior (100%) infection
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n cats living under ﬁeld conditions. In addition, the same
ombination product was conﬁrmed to be highly efﬁca-
ious against naturally acquired gastrointestinal parasites
e.g., T. cati, hookworms, tapeworms), also in the case of
ultiple infections, under ﬁeld conditions (Rehbein et al.,
014). In the present study, the enrolled cats probably
arboured different developmental stages of lungworms,
ince they were infected under natural conditions. This
omplements the results obtained from a controlled lab-
ratory study, in which the efﬁcacy of the product against
hird- and fourth-stage larvae of A. abstrusus was assessed
Knaus et al., 2014a). Whether repeated monthly treat-
ents would increase the efﬁcacy of the product in cats
nfected by A. abstrusus should be deﬁned.
In conclusion, Broadline® spot-on was proven to be
ighly effective against both A. abstrusus and T. brev-
or under ﬁeld conditions, by reducing signiﬁcantly larval
hedding. All treated cats recovered from respiratory signs.
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